每年研究成果
研究成果
2019
Tolerability of rifapentine-based regimens in latent tuberculosis infection treatment in the elderly
Chan, P. C., Lee, P. H., Lu, M. J., Huang, Y. C., Feng, T. Y., Chen, W. W., Lee, C. C., Huang, Y. F. & Chiang, C. Y., 三月 1 2019, 於 : The European respiratory journal. 53, 3研究成果: 雜誌貢獻 › 快報
開啟存取
2
引文
斯高帕斯（Scopus）
2017
Gefitinib or erlotinib for previously treated lung adenocarcinoma: Which is superior?
Chang, C. H., Lee, C. H. & Wang, J. Y., 四月 20 2017, 於 : Journal of Clinical Oncology. 35, 12, p. 1374 1 p.研究成果: 雜誌貢獻 › 快報
3
引文
斯高帕斯（Scopus）
Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistance
Van Deun, A. & Chiang, C. Y., 六月 1 2017, 於 : European Respiratory Journal. 49, 6, 1700223.研究成果: 雜誌貢獻 › 快報
12
引文
斯高帕斯（Scopus）
Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan
Lee, M. R., Ho, C. M., Lee, C. H., Lee, M. C., Chang, L. Y., Yu, K. L., Ko, J. C., Wang, J. Y., Wang, J. T. & Lee, L. N., 八月 1 2017, 於 : The European respiratory journal. 50, 2研究成果: 雜誌貢獻 › 快報
10
引文
斯高帕斯（Scopus）
2015
Coinfection of Pneumocystis jiroveci pneumonia and pulmonary tuberculosis in a non-HIV-infected patient
Suk, C. W., Bai, K-J., Yu, M-C. & Hu, T. Y., 十二月 1 2015, 於 : Journal of Microbiology, Immunology and Infection. 48, 6, p. 711-712 2 p.研究成果: 雜誌貢獻 › 快報
2
引文
斯高帕斯（Scopus）
2009
Weekly cetuximab and gemcitabine plus cisplatin as salvage therapy for unresectable non-small cell lung cancer
Tai, C. J., Hsu, C. H., Wang, F. J., Chau, W. K., Chung, C. L. & Hsieh, C. C., 十一月 2009, 於 : Onkologie. 32, 11, p. 685-686 2 p.研究成果: 雜誌貢獻 › 快報